Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 132,080,272
- Total 13F value
- $1,309,587,378
- Share change
- +13,688,192
- Put/Call ratio
- 18%
- SEC-reported price per share
- $9.89
- Number of holders
- 185
- Value change
- +$125,586,082
- Number of buys
- 113
- Number of sells
- 53
- Shares outstanding
- 305,667,944
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
185
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DCVC Bio, L.P.
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
0/15
Latest evidence
30 Jun 2022
3/4/5
13F
Highest disclosed value: $142,227,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO has the largest disclosed position value at $142.23M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Disclosed position value
Top 5
DCVC Bio, L.P.
$199.5K
BAILLIE GIFFORD & CO
$142.23M
Capital World Investors
$138.86M
BlackRock Finance, Inc.
$125.94M
Allianz Asset Management GmbH
$115.26M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DCVC Bio, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$199,508
73,892 shares
|
— | 18 Jun 2021 |
| BAILLIE GIFFORD & CO |
13F
Company
|
—
denominator unverified
|
$142,227,000
13,354,715 shares
|
— | 30 Jun 2022 |
| Capital World Investors |
13F
Company
|
—
denominator unverified
|
$138,859,000
13,038,357 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$125,940,000
11,825,332 shares
|
— | 30 Jun 2022 |
| Allianz Asset Management GmbH |
13F
Company
|
—
denominator unverified
|
$115,260,000
10,822,530 shares
|
— | 30 Jun 2022 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$111,294,000
10,450,180 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
185
Shares
132,080,272
Rows available
185
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
160
Q3 2022 holders
185
Holder diff
25
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|